Heska Corporation

119.99
0.00 (0.00%)
At close: Jun 12, 2023, 8:00 PM

Company Description

Heska Corporation sells veterinary and animal health diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Mexico, Australia, France, Germany, Italy, Malaysia, Spain, and Switzerland.

The company offers Element DC, Element DCX, Element DC5x veterinary chemistry analyzers for blood chemistry and electrolyte analysis; Element RC, Element RCX, and Element RC3X chemistry systems for blood chemistry and electrolyte analysis; Element HT5 and scil Vet abc Plus veterinary hematology analyzers to measure blood cell and platelet count, and hemoglobin levels; Element POC blood gas and electrolyte analyzers; Element i immunodiagnostic analyzers; and Element COAG and Element AIM veterinary analyzers.

It also provides HeskaView Telecytology that provides in-clinic automated microscopic slide scanning and computing equipment; IV infusion pumps; digital radiography hardware and mobile digital radiography products; ultrasound systems; Cloudbank, a Web-based image storage solution; point-of-care products to detect antigens and antibodies associated with infectious and parasitic diseases of animals; Tri-Heart Plus chewable tablets for the treatment of canine heartworm infection, and ascarid and hookworm infections; and allergy products and services, including ALLERCEPT definitive allergen panels, and therapy shots or drops.

In addition, the company provides a line of bovine vaccines; biological and pharmaceutical products to other animal health companies; and turnkey services comprising research, licensing, production, labeling, and packaging; and validation support and distribution services.

It sells its products to veterinarians through a telephone sales force, and third-party distributors; and trade shows, print advertising, and other distribution relationships.

The company was formerly known as Paravax, Inc. and changed its name to Heska Corporation in 1995.

The company was founded in 1988 and is based in Loveland, Colorado.

Heska Corporation
Heska Corporation logo
Country United States
IPO Date Jul 1, 1997
Industry Medical - Devices
Sector Healthcare
Employees 808
CEO Kevin S. Wilson

Contact Details

Address:
3760 Rocky Mountain Avenue
Loveland, Colorado
United States
Website https://www.heska.com

Stock Details

Ticker Symbol HSKA
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001038133
CUSIP Number 42805E306
ISIN Number US42805E3062
Employer ID 77-0192527
SIC Code 2835

Key Executives

Name Position
Dr. Nancy Wisnewski Ph.D. Chief Science Advisor to Chief Executive Officer
Kevin S. Wilson Chief Executive Officer, Pres & Director
Catherine I. Grassman CPA Executive Vice President & Chief Financial Officer
Dr. Nancy Wisnewski Executive Vice President & Chief Operating Officer
Eleanor F. Baker Executive Vice President, MD & Chief Operating Officer of Scil Animal Care Company
Anthony C. Providenti Jr. Executive Vice President of Corporation Devel.
Christopher D. Sveen EVice President, Chief Admn. Officer, Gen. Counsel, Corporation Sec. & Pres of Diamond Animal Health
Cynthia Patterson Vice President of Customer Care
Daniel J. Pollack Vice President of Imaging Operations, Treasurer & Assistant Sec.
Jon Aagaard Director of Investor Relations
Laurie E. Peterson Vice President of Heska Des Moines
Steven M. Eyl Executive Vice President, Chief Commercial Officer & Pres of scil animal care company

Latest SEC Filings

Date Type Title
Jun 23, 2023 15-12G Filing
Jun 14, 2023 4 Filing
Jun 14, 2023 4 Filing
Jun 14, 2023 4 Filing
Jun 14, 2023 4 Filing
Jun 14, 2023 4 Filing
Jun 14, 2023 4 Filing
Jun 14, 2023 4 Filing
Jun 14, 2023 4 Filing
Jun 14, 2023 4 Filing